| Literature DB >> 26264033 |
Joachim Habel1,2, Michael Hansen3, Søren Kynde4, Nanna Larsen5, Søren Roi Midtgaard6, Grethe Vestergaard Jensen7, Julie Bomholt8, Anayo Ogbonna9, Kristoffer Almdal10, Alexander Schulz11, Claus Hélix-Nielsen12,13,14.
Abstract
In recent years, aquaporin biomimetic membranes (ABMs) for al">water separation have gained considerable interest. Although the first ABMs are commercially available, there are still many challenges associated with further ABM development. Here, we discuss the interplay of the main components of ABMs: aquaporin proteins (AQPs), block copolymers for AQP reconstitution, and polymer-based supporting structures. First, we briefly cover challenges and review recent developments in understanding the interplay between AQP and block copolymers. Second, we review some experimental characterization methods for investigating AQP incorporation including freeze-fracture transmission electron microscopy, fluorescence correlation spectroscopy, stopped-flow light scattering, and small-angle X-ray scattering. Third, we focus on recent efforts in embedding reconstituted AQPs in membrane designs that are based on conventional thin film interfacial polymerization techniques. Finally, we describe some new developments in interfacial polymerization using polyhedral oligomeric silsesquioxane cages for increasing the physical and chemical durability of thin film composite membranes.Entities:
Keywords: aquaporins; biomimetic membranes; block copolymers; membrane proteins; microfluidics; polyamide layer; polyhedral oligomeric silsesquioxanes; protein-polymer-interactions; proteopolymersomes
Year: 2015 PMID: 26264033 PMCID: PMC4584284 DOI: 10.3390/membranes5030307
Source DB: PubMed Journal: Membranes (Basel) ISSN: 2077-0375
Figure 1Schematic drawing of aggregate morphologies as a function of mPAR. PB12-PEO10 undergoes four transitions. Surprisingly, the vesicle shape remained at significantly higher densities at block copolymers, compared to a standard lipid like 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE). The mPAR of the one-molecule-bilayer-forming ABA triblock copolymers was divided by two enabling direct comparison with the PB-PEO diblock copolymers and DOPE, both forming bilayers. The morphologies in full color are the main morphologies, pale colors denote coexisting morphologies. Adapted from [34].
Figure 2TEM images of aggregate morphologies as a function mPAR. Where the PMOXA-PDMS-PMOXA copolymers self-assemble to vesicles, PB-PEO forms network- and sperm-like structures and only after incorporation of AQP0 vesicular structures are observed. Scale bar is 200nm. Adapted from [33].
Overview of studies of membrane protein incorporation into amphiphilic block copolymers. Most studies are done with the porin OmpF, followed by AqpZ. For explanations please refer to the list of abbreviations.
| Polymer | M | PDI | Membrane Protein | Transport Cargo | FI? | mPAR | S | Incorporation method Main Functional incorporation measurement | References | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| PMOXA13–PDMS23–PMOXA13 | 3.9 | e− | X | 1:3300 | V | MAq, biobeads & SEC | Cargo → Reduction of MP → EPR signal | [ | |||
| PMOXA13–PDMS23–PMOXA13 | 4.7 | NA | 0.44 | Alamethicin | X | 1:590 | P | MAq | Current change | [ | |
| PMOXA13–PDMS23–PMOXA13 | 4.7 | NA | 0.44 | Hemolysin | X | 1:110,000,000 | P | MAq | Current change | [ | |
| PMOXA13–PDMS23–PMOXA13 | 4.7 | NA | 0.44 | OmpG | X | 1:33,000,000 | P | MAq | Current change | [ | |
| PMOXA20-PDMS41-PMOXA20 | 6.4 | 1.61 | 0.49 | NtAQP1 | CO2 | X | 1:360 | P | MOr | Cargo → Reaction inside vesicle → pH change | [ |
| PMOXA20-PDMS41-PMOXA20 | 6.4 | 1.61 | 0.49 | NtPIP2:1 | CO2 | X | 1:360 | P | MOr | Cargo → Reaction inside vesicle → pH change | [ |
| PMOXA20-PDMS41-PMOXA20 | 6.5 | <1.2 | 0.51 | AQP0 | H2O | ND | 10:1–1:1 | P | MAq & dialysis | [ | |
| PMOXA20-PDMS41-PMOXA20 | 6.5 | <1.2 | 0.51 | AQP0 | H2O | ND | 10:1–1:50 | V | MAq & dialysis | [ | |
| PMOXA20-PDMS41-PMOXA20 | 6.5 | <1.2 | 0.51 | AQP0 | H2O | - | 1:2.5–0 | V | MAq & dialysis | Vesicle size change | [ |
| PMOXA12-PDMS54-PMOXA12 | 6.0 | 1.01 | 0.2 | AqpZ | H2O | X | 1:100–1:1600 | V | MAq & biobeads | Vesicle size change | [ |
| PMOXA19-PDMS74-PMOXA19 | 8.7 | 1.46 | 0.23 | ||||||||
| PMOXA12-PDMS54-PMOXA12 | 6.0 | 1.01 | 0.30 | AqpZ | H2O | X | 1:50–1:400 | V | MAq & biobeads | Vesicle size change | [ |
| PMOXA12-PDMS54-PMOXA12 | 6.0 | 1.01 | 0.30 | Hemolysin | - | 1:83,000,000 | P | MAq | Current change | [ | |
| PMOXA20-PDMS54-PMOXA20 | 7.4 | NA | 0.42 | TsX | Nucleosides | X | 1:450 | V | MOr, SI & SEC | Cargo → Encapsulated enzyme activity → Color change | [ |
| PMOXA8-PDMS55-PMOXA8 | 5.4 | NA | 0.22 | AqpZ | H2O | X | 1:3500 | V | PFR, biobeads & SEC | Vesicle size change | [ |
| PMOXA12-PDMS55-PMOXA12 | 6.1 | 1.64 | 0.30 | OmpF | ELF97 | X | 1:1200 | V | MAq & SEC Cargo | Precipitation inside vesicle → Color change | [ |
| PMOXA12-PDMS55-PMOXA12 | 6.1 | 1.64 | 0.30 | OmpF | Acridine orange | X | 1:9,100,000 | V | PPFR & SEC | Cargo release → Color change | [ |
| PMOXA12-PDMS55-PMOXA12 | 6.1 | 1.64 | 0.30 | OmpF | Paraquat. Pyocyanin | X | 1:640 | V | MAq & dialysis | No cargo → No detoxication of encapsulated enzyme | [ |
| PMOXA12-PDMS55-PMOXA12 | 6.1 | 1.64 | 0.30 | AQP0 | H2O | ND | 10:1–1:25 | P | MAq & dialysis | [ | |
| PMOXA12-PDMS55-PMOXA12 | 6.1 | 1.64 | 0.30 | AQP0 | H2O | - | 1:3–0 | V | MAq & dialysis | Vesicle size change | [ |
| PMOXA12-PDMS55-PMOXA12 | 6.1 | 1.64 | 0.30 | AqpZ | H2O | ND | 1:4 | Cr. V | MAq & biobeads | [ | |
| PMOXA7-PDMS60-PMOXA7 | 5.6 | NA | 0.19 | Gramicidin A | Monovalent cations | X | 1:81,000 | P | MOr | Current change | [ |
| PMOXA8-PDMS60-PMOXA8 | 5.8 | NA | 0.21 | AqpZ | H2O | X | 1:3800 | V | PFR, biobeads & SEC | Vesicle size change | [ |
| PMOXA13-PDMS62-PMOXA13 | 6.8 | 1.47 | 0.29 | NADH reductase | e− | X | 1:1900 | V | MAq, biobeads & SEC | Cargo → Reduction of MP → EPR signal | [ |
| PMOXA15-PDMS62-PMOXA15 | 7.1 | 1.50 | 0.32 | NADH reductase | e− | X | 1:1800 | V | MAq, biobeads & SEC | Cargo → Reduction of MP → EPR signal | [ |
| PMOXA12-PDMS65-PMOXA12 | 6.9 | 1.67 | 0.27 | MloK1 | Potassium | X | 1:390 | P | MAq & biobeads | Current change | [ |
| PMOXA15-PDMS68-PMOXA15 | 7.6 | NA | 0.30 | LamB | Maltohexaose | X | NA | P | MAq | Current change at varying cargo concentrations | [ |
| PMOXA15-PDMS68-PMOXA15 | 7.6 | NA | 0.30 | OmpF | Actylthiocholine | X | 1:10000 | V | PFR | Cargo → Encapsulated enzyme activity → Color change | [ |
| PMOXA15-PDMS68-PMOXA15 | 7.6 | 1.20 | 0.30 | AqpZ | H2O | X | 1:10–1:1000 | V | PFR & biobeads | Vesicle size change | [ |
| PMOXA15-PDMS68-PMOXA15 | 7.6 | 1.20 | 0.30 | Hemolysin | 1:66,000,000 | V | MAq | Current change | [ | ||
| PMOXA21-PDMS69-PMOXA21 | 8.7 | 2.00 | 0.37 | NADH reductase | e− | X | 1:1500 | V | MAq, biobeads & SEC | Cargo → Reduction of MP → EPR signal | [ |
| PMOXA16-PDMS72-PMOXA16 | 8.0 | 1.17 | 0.30 | OmpF | Enone | X | 1:220 | V | PPFR & dialysis | Cargo → Encapsulated enzyme activity → Color change | [ |
| PMOXA-PDMS-PMOXA | 8.8 | NA | NA | OmpF | ELF97 | X | 1:50 | V | MAq & SEC | Cargo → Precipitation inside vesicle → Color change | [ |
| PMOXA32-PDMS72-PMOXA32 | 10.7 | 1.83 | 0.47 | OmpF | 7-ADCA. PGME | X | NA | V | PFR & dialysis | Cargo → Encapsulated enzyme activity → Bacterial death | [ |
| PMOXA11-PDMS73-PMOXA11 | 7.2 | 1.70 | 0.22 | LamB | DNA | X | 1:390 | V | MOr, SI & SEC | Fluorescence-labelled cargo | [ |
| PMOXA11-PDMS73-PMOXA11 | 7.2 | 1.70 | 0.22 | OmpF | Nucleosides | X | 1:10, 1:100 | V | PPFR & SEC | Cargo → Encapsulated enzyme activity → Color change | [ |
| PMOXA11-PDMS73-PMOXA11 | 7.2 | 1.70 | 0.22 | TsX | Nucleosides | X | 1:10, 1:100 | V | PPFR & SEC | Cargo → Encapsulated enzyme activity → Color change | [ |
| PMOXA11-PDMS73-PMOXA11 | 7.2 | 1.70 | 0.22 | LamB | DNA | X | NA | P | MAq | [ | |
| Lipids | |||||||||||
| PMOXA21-PDMS73-PMOXA21 | 9.0 | 1.70 | 0.36 | Alamethicin | Calcium | X | 1:24 | V | MAq | Cargo precipitation inside vesicle | [ |
| PMOXA21-PDMS73-PMOXA21 | 9.0 | 1.70 | 0.36 | FhuA | Sulphorhodamine B | X | 1:6,000,000 | V | MOr, SI & SEC | Cargo → Quenching inside vesicle → Color change | [ |
| PMOXA21-PDMS73-PMOXA21 | 9.0 | 1.70 | 0.36 | FhuA | TMB | X | 1:4500. 1:3,600,000 | V | MAq/ & biobeads/MOr, SI & SEC | Cargo → Encapsulated enzyme activity → Color change | [ |
| PMOXA21-PDMS73-PMOXA21 | 9.0 | 1.70 | 0.36 | FhuA | ND | 3000:1 | P | MAq | [ | ||
| PMOXA21-PDMS73-PMOXA21 | 9.0 | 1.70 | 0.36 | FhuA | NAD | - | NA | V | MAq | Cargo → Encapsulated enzyme activity | [ |
| PMOXA21-PDMS73-PMOXA21 | 9.0 | 1.70 | 0.36 | FhuA | DNA | - | NA | V | MOr, SI & SEC | Fluorescence-labelled cargo | [ |
| PMOXA21-PDMS73-PMOXA21 | 9.0 | 1.70 | 0.36 | LamB | Sugar | X | NA | P | MAq | Current change at varying cargo concentration | [ |
| PMOXA21-PDMS73-PMOXA21 | 9.0 | 1.70 | 0.36 | OmpF | e− | X | NA | P | MAq | Current change | [ |
| PMOXA21-PDMS73-PMOXA21 | 9.0 | 1.70 | 0.36 | OmpF | Ampicillin | X | 1:1000 | V | MOr & SEC | Cargo → Hydrolysis inside vesicle → Color change | [ |
| PMOXA20-PDMS75-PMOXA20 | 9.0 | 1.46 | 0.34 | AqpZ | H2O | X | 1:25, 1:50, 1:200 | V | PFR & biobeads | Vesicle size change | [ |
| PMOXA11-PDMS76-PMOXA11 | 7.8 | 1.48 | 0.25 | BR | H+ | X | NA | V/Mc | MOr & SI | pH change | [ |
| PMOXA11-PDMS76-PMOXA11 | 7.8 | 1.48 | 0.25 | BR & ATPase | H+ | X | 1:180 | V | MOr & dialysis | pH change & bioluminescence assay | [ |
| PMOXA11-PDMS76-PMOXA11 | 7.8 | 1.48 | 0.25 | BR & ATPase | H+ | X | 1:20 | V | PBR & dialysis | pH change | [ |
| PMOXA6-PDMS90-PMOXA6 | 9.5 | NA | 0.12 | OmpF | L-ascorbic acid, CO, Na2 S2 O4, ONOO− | X | 1:1300 | V | PFR, dialysis & SEC | Cargo → Absorbance change of encapsulated protein | [ |
| PMOXA21-PDMS97-PMOXA21 | 9.0 | 1.70 | 0.30 | Hemaglutinin | X | 1:3800 | V | MAq & biobeads | MP → Fusion with fluorescence-labelled liposomes | [ | |
| PMOXA9-PDMS106-PMOXA9 | 9.4 | 1.38 | 0.14 | NADH reductase | e− | X | 1:1400 | V | MAq, biobeads & SEC | Cargo → Reduction of MP → EPR signal | [ |
| PMOXA13-PDMS110-PMOXA13 | 10.4 | 1.44 | 0.19 | NADH reductase | e− | X | 1:1200 | V | MAq, biobeads & SEC | Cargo → Reduction of MP → EPR signal | [ |
| PMOXA14-PDMS110-PMOXA14 | 10.5 | 1.36 | 0.20 | NADH reductase | e− | X | 1:1200 | V | MAq, biobeads & SEC | Cargo → Reduction of MP → EPR signal | [ |
| PMOXA15-PDMS110-PMOXA15 | 10.7 | 1.62 | 0.21 | AqpZ | H2O | X | 1:25–1:500 | V | PFR & SEC | Vesicle size change | [ |
| PMOXA15-PDMS110-PMOXA15 | 10.7 | 1.62 | 0.21 | OmpF | ND | NA | P | MAq | [ | ||
| PMOXA-PDMS-PMOXA | 20.0 | NA | FhuA | Calcein | X | 1:2,700,000 | V | MOr, SI & SEC | Cargo release → Color change | [ | |
| PMOXA65-PDMS165-PMOXA65 | 23.3 | 1.63 | NADH reductase | e− | X | 1:550 | V | MAq, biobeads & SEC | Cargo → Reduction of MP → EPR signal | [ | |
| PMOXA-PDMS-PMOXA | NA | NA | NA | BR | H+ | X | NA | P | MAq | pH change | [ |
| PMOXA-PDMS-PMOXA | NA | NA | NA | BR & CcO | H+ & e− | X | NA | V | MOr, SI & SEC | Current & pH change | [ |
| PMOXA-PDMS-PMOXA | NA | NA | NA | CcO | e− | X | NA | P | MOr, SI & SEC | Current change | [ |
| PMOXA-PDMS-PMOXA | NA | NA | NA | OmpF | H+ | X | NA | P | MAq | Current change | [ |
| PMOXA110-PDMS40-PEO25 | 13.4 | NA | 0.75 | AQP0 | H2O | ND | 1:200 | V | MOr, SI & SEC | [ | |
| PMOXA45-PDMS40-PMOXA67 | 10.6 | NA | 0.68 | AQP0 | H2O | ND | 1:200 | V | MOr, SI & SEC | [ | |
| MPEG-PVL | 6.5 | <1.2 | 0.00 | Polymyxin B | Calcein | X | 1:2 | V | MAq | Cargo release → Color change | [ |
| P2VP-PEO | NA | NA | NA | FhuA | NAD | - | NA | V | MOr, SI & SEC | Cargo → Enzyme reaction inside vesicle → Absorbance change of cargo | [ |
| PB12-PEO10 | 1.1 | 1.09 | 0.32 | AQP0 | H2O | X | 1:5–1:250 | V | MAq & dialysis | Vesicle size change | [ |
| PB12-PEO10 | 1.1 | 1.09 | 0.32 | AQP0 | H2O | ND | 1:1.3 | Cr | MAq & dialysis | [ | |
| PB12-PEO10 | 1.1 | 1.09 | 0.32 | AQP0 | H2O | ND | 1:1–1:10 | P | MAq & dialysis | [ | |
| PB12-PEO10 | 1.1 | 1.09 | 0.3 | AqpZ | H2O | X | 1:50-1:1000 | V | MAq & dialysis | Vesicle size change | [ |
| PB12-PEO10 | 1.1 | 1.09 | 0.32 | BR | H+ | X | 1:500 | V | MAq & biobeads | pH change | [ |
| PB12-PEO10 | 1.1 | 1.09 | 0.3 | SoPIP2;1 | H2O | - | 1:200 | V | MAq & biobeads | Vesicle size change | [ |
| PB12-PEO10 | 1.1 | NA | 0.34 | Hemolysin | Calcein | X | 1:33,000 | V | MAq & dialysis | Cargo release → Color change | [ |
| PB22-PEO14 | 1.8 | 1.17 | 0.28 | AQP0 | H2O | ND | 2:1–1:300 | P | MAq & dialysis | [ | |
| PB22-PEO23 | 2.2 | 1.09 | 0.39 | AqpZ | H2O | X | 1:15–1:200 | V | MAq & dialysis | Vesicle size change | [ |
| PB22-PEO23 | 2.2 | 1.09 | 0.39 | SoPIP2;1 | H2O | - | 1:15, 1:200 | V | MAq & dialysis | Vesicle size change | [ |
| PB29-PEO16 | 2.3 | 1.00 | 0.25 | AQP10 | H2O | - | 1:990 | V | PFR & SE | Vesicle size change | - |
| PB35-PEO14 | 2.5 | 1.09 | 0.19 | AqpZ | H2O | - | 1:15 | V | MAq & dialysis | Vesicle size change | [ |
| PB35-PEO14 | 2.5 | 1.09 | 0.19 | SoPIP2;1 | H2O | - | 1:15 | V | MAq & dialysis | Vesicle size change | [ |
| PB43-PEO32 | 3.7 | 1.03 | 0.31 | AQP10 | H2O | X | 1:600 | V | PFR & SE | Vesicle size change | [ |
| PB46-PEO30 | 3.8 | 1.04 | 0.28 | AqpZ | H2O | - | 1:50,1:100,1:200 | V | MAq & dialysis | Vesicle size change | [ |
| PB46-PEO32 | 3.9 | 1.00 | 0.30 | AQP10 | H2O | - | 1:580 | V | PFR & SE | Vesicle size change | - |
| PB52-PEO29 | 4.1 | <1.1 | 0.25 | Hemolysin | e− | X | NA | P | MAq | Current change | [ |
| PB52-PEO29 | 4.1 | <1.1 | 0.25 | Polymyxin B | X | NA | P | MAq | Current change | [ | |
| PB52-PEO29-LA | 4.1 | <1.1 | 0.25 | Hemolysin | e− | X | NA | P | MAq | Current change | [ |
| PB52-PEO29-LA | 4.1 | <1.1 | 0.25 | Polymyxin B | X | NA | P | MAq | Current change | [ | |
| PB92-PEO78 | 8.4 | 1.08 | 0.34 | AQP10 | H2O | - | 1:270 | V | PFR & SE | Vesicle size change | - |
| PB125-PEO80 | 8.9 | <1.1 | 0.28 | Alamethicin | Calcein | - | 1:2-1:8 | V | MAq | Cargo release → Color change | [ |
| PHEMA25-PBMA25-PHEMA25 | 14.3 | 1.30 | 0.83 | AqpZ | - | NA | P | MAq & biobeads | Current change | [ | |
| PHEMA25-PBMA25-PHEMA25 | 14.3 | 1.30 | 0.83 | Hemolysin | X | NA | P | MAq | Current change | [ | |
| PHEMA25-PBMA25-PHEMA25 | 14.3 | 1.30 | 0.83 | OmpF | - | 1:70 | P | MAq & biobeads | Current change | [ | |
| PEE37-PEO40 | 3.9 | <1.1 | 0.39 | Alamethicin | Calcein | X | 1:2–1:8 | V | MAq | Cargo release → Color change | [ |
| PPO34-PGM14 | 6.5 | 1.30 | 0.66 | Strepatividin-BSA | ND | 1:5, 1:15, 1:50 | V | PPFR | [ | ||
| PI93-PEO87 | 10.2 | 1.00 | 0.31 | FhuA | TMB | X | 1:6700. 1:5,300,000 | V | MOr, SI & SEC | Cargo → Encapsulated enzyme activity → Color change | [ |
| PEO136-PIB18-PEO136 | 8.0 | 1.86 | 0.90 | Cecropin A | Calcein | X | 1:30 | V | MAq & SEC | Cargo release → Color change | [ |
| P4MVP21-PS26-P4MVP21 | 13.1 | NA | 0.80 | PR | X | 1:10 | V | MAq & precipitation | Absorbance change in membrane protein | [ | |
| P4MVP21-PS38-P4MVP21 | 14.3 | 1.19 | 0.74 | PR | X | 1:10 | V | MAq & precipitation | Absorbance change in membrane protein | [ | |
| P4MVP29-PS42-P4MVP29 | 18.7 | NA | 0.78 | PR | X | 1:10 | V | MAq & precipitation | Absorbance change in membrane protein | [ | |
| P4MVP22-PB28-P4MVP22 | 15.0 | NA | 0.92 | PR | ND | 1:10 | V | MAq & precipitation | [ | ||
| P4MVP22-PB28-P4MVP22 | 15.0 | NA | 0.92 | RC | e− | X | 1:25 | V | MAq & precipitation | Cargo → Reduction of MP → EPR signal | [ |
| P4VP22-PB28-P4VP22 | 7.1 | NA | 0.82 | PR | ND | 1:10 | V | MAq & precipitation | [ | ||
| P4MVP29-PB56-P4MVP29 | 17.4 | 1.08 | 0.81 | RC | e− | X | 1:25 | V | MAq & precipitation | Cargo → Reduction of MP → EPR signal | [ |
| P4MVP18-PB93-P4MVP18 | 13.9 | 1.06 | 0.62 | PR | ND | 1:10 | V | MAq & precipitation | [ | ||
Figure 3Overview of relevant parameters for membrane protein incorporation into amphiphilic block copolymers.
Figure 4Normalized light scattering vs. time for proteo- and polymersomes of PB45-PEO14 and PB33-PEO18 at an mPAR of 1:100. For PB45-PEO14 the apparent water permeability is slightly decreased for the proteopolymersomes versus polymersomes, whereas for PB33-PEO18 it is slightly increased.
Figure 5FF-TEM images of PB45-PEO14 proteo—(b,c,e,f) and polymersomes (a,d). All vesicles revealed spots, potentially not from AqpZ but rather collapsed PB chains (a–c) or bad fracturing artifacts (d–f). Scale bar is 100 nm.
Figure 6(a) Correlation diagram of proteopolymersomes and AQP10-GFP stock solution as a function of correlation time τ against autocorrelation function G(τ). The higher autocorrelation signal indicates a lower number of particles in the confocal volume, due to slower diffusion time. (b) Fluorescence lifetimes of the same samples as a function of lifetime against intensity signal. Where the intensities varied, the fluorescence lifetime was in a comparable range.
Figure 7SAXS data for proteo- and polymersomes of PB45-PEO14 (a) and PB33-PEO18 (b). The fits were obtained using a vesicle model consisting of three concentric spherical shells. To fit the polymersomes of PB33-PEO18, it was necessary to include an additional contribution from block-copolymer micelles as shown in the insert.
Figure 8Schematic overview of all published designs for ABPMs and ABLMs. Pioneer work is mainly done by Kumar and Aquaporin AIS. The most experimental designs has been done by NUS, where NTU published the most promising layer embedment ABLMs. The main recent work is on LbL-based electrostatic binding, for example binding of proteoliposomes on a polyelectrolyte layer [142].
Figure 9Chemical structure of POSS and TMC and the resulting AL. POSS as the amine linker generate a highly stable and well-defined AL with TMC.
Figure 10FTIR diagram of POSS/polymersomes+TMC AL (labelled red) and POSS+TMC control AL (labelled blue) as a function of wavelength against absorption. The AL with polymersomes had an absorption peak around 3000 cm−1, that responds to PB and PEO, indicating their presence in the AL, where the characteristic absorption peaks for PA bonds and POSS were present as well.
Figure 11SEM images of POSS+TMC AL (a,b) and of POSS/polymersomes+TMC AL (c–e) with schematic sketches, which part of the layer is being captured. Images were taken from different parts of the flakes (labelled green in the sketch) of the AL, that were generated during the SEM preparation. The AL without polymersomes was smooth and well-defined, which remained on the organic side when polymersomes were added. The aqueous side was covered with loosely attached and half-covered polymersomes (dotted circle in (d)). A few could be observed inside the AL (arrows in (d)). Scale bar is 3 µm.
Figure 12(a) Schematic sketch of the microfluidic chamber and micrographs of POSS/proteopolymersomes+TMC AL and (b) micrograph of the compartment. The aqueous phase reached into the other compartment. After introducing the organic phase, a well-defined AL formed. Scale bar is 50 µm.
Figure 13FTIR analysis of supported POSS/polymersomes+TMC AL (red) and POSS+TMC control AL (blue) on MF PES and pure MF PES (black). The PES supporting material had high absorption and interfered with many absorption peaks. A subtraction from the absorption spectra of pure PES resulted in negative peaks. We therefore only normalized the spectra. PB-PEO was present in the AL with polymersomes; however, the PA formation was strongly suppressed.
Figure 14SEM images of MF PES (a,b) supported POSS+TMC AL on MF PES (c) and supported POSS/polymersomes+TMC on MF PES (d,e). Schematic sketch of polymersome coverage left to (e). Micropores of the MF PES were covered completely by the POSS+TMC AL. After addition of polymersomes, small bumps with dimensions similar to the polymersomes were observed on the organic faced side of the AL. Greater bumps may be attributed to accumulations of covered polymersomes. Scale bar is 3 µm.